Dr. Chan Tak Lam Norman (Chairman): Dr. Norman Chan has a long and distinguished career in banking and finance. Dr. Norman Chan was Chief Executive of the HKMA from October 2009 to September 2019. He is primarily responsible for formulating and overseeing strategic direction of our Company.

Ms. Tsang King Suen Katherine (Chief Executive Officer): Ms. Katherine Tsang is a well-recognised member of the Asian financial and business community. Ms. Tsang worked in Standard Chartered Bank for 22 years and was the bank’s Chairperson of Greater China from August 2009 to August 2014. She is primarily responsible for overseeing the overall management and strategic planning of our Company.

Dr. Wong Shue Ngar Sheila (Chief Operating Officer): Dr. Wong has over 30 years of managerial experience in leading multinational companies of different industries. Dr. Wong is also the sole shareholder, the Manager in Charge and Director of Max Giant. She is primarily responsible for overseeing the operations, administration and financial matters of our Company. Dr. Wong has been licensed by the SFC to carry out Type 9 (asset management) regulated activity since December 2017. She has been accredited to the principal and approved as the responsible officer for Type 9 (asset management) regulated activity of Max Giant since December 2017.

Mr. Tsang Hing Shun Thomas (Chief Investment Officer): Mr. Tsang has over 13 years of experience in investment industry. From November 2008 to May 2014, Mr. Tsang worked at Hony Capital, a private equity firm, as an Investment Manager and was responsible for fund raising, deal sourcing, cross-border investments, portfolio management and capital markets activities for funds in Hong Kong and the Asian region. He is responsible for overseeing investor relations and investment decisions of our Company. Mr. Tsang has been licensed by the SFC to carry out Type 4 (advising on securities) and Type 9 (asset management) regulated activities, and approved as the responsible officer of Max Giant, since February 2019 and June 2014.

Mr. Hui has over 50 years of experience in the securities and investment industry. Mr. Hui has been licensed by the SFC to carry out Type 1 (dealing in securities), Type 2 (dealing in future contract), Type 4 (advising on securities), Type 5 (advising on future contract), Type 6 (advising on corporate finance) and Type 9 (asset management) regulated activities since February 2005, December 2011, June 2012, February 2015, July 2017 and December 2013.

Mr. Wong has over 40 years of professional accountancy and managerial experience in the transport and logistics industry.

Prof. Tang has over 40 years of professional medical, education and managerial experience.

Mr. Zhang has over 35 years of experience in the banking industry in both mainland China and Hong Kong.

Dr. Lam has over 40 years of extensive international experience in corporate management, strategy consulting, corporate governance, direct investment, investment banking and asset management. He will advise on the strategic development and investment of our Company, provide professional insights in identifying and assessing the suitability of potential De-SPAC targets and contribute industry-specific guidance on the De-SPAC transaction.

In addition to their executive directorship in our Company, Dr. Norman Chan, Ms. Katherine Tang, Dr. Sheila Wong and Mr. Thomas Tsang are also our senior management members.